• Submit news
  • Advertise & rates
  • Contact us

Subscribe to industry newsletters

Bizcommunity has over 400 industry contributors and we always welcome further contributions and contributors.
Advertise with us
Advertise & RatesMy Account
Company press officeList company
Recruitment packagesSubmit job ad
Download ratecard
Pharmaceutical Companies news

Cipla Medpro's chief financial officer quits

South Africa's third biggest pharmaceutical company Cipla Medpro announced on Monday (26 November) that its chief financial officer Chris Aucamp had resigned with immediate effect‚ but would remain a director of one of its subsidiaries Medpro Pharmaceutical until at least the end of March.
Ordinarily the resignation of a company's chief financial officer would not elicit much attention‚ but Aucamp's resignation comes shortly after Cipla Medpro founder Jerome Smith quit following allegations of financial irregularities. These included Smith paying himself R3.6m in unauthorised bonuses - which he has paid back - and taking undeclared interest-free loans from the firm.

Vunani Securities analyst Anthony Clark said Aucamp's departure was not unexpected as the new senior management team at Cipla Medpro needed to be seen to be making changes in order to improve the company's image in the eyes of investors.

"I'm surprise it didn't happen earlier because as CFO he should have been aware of what was happening at a governance level‚" said Asief Mohamed‚ an analyst at Aeon Investment Management.

Neither Aucamp nor the company's acting chief executive Johan du Preez would elaborate on the reasons for his departure.

"I am not at liberty to comment‚" said Aucamp‚ referring queries to Du Preez.

Du Preez said the board had chosen to handle the matter internally and restrict its comments to a statement issued via the JSE's news service. No disciplinary enquiry had been held into Aucamp's conduct‚ he said.

Cipla Medpro said company secretary Mark Daly had been appointed chief financial officer and an executive director of the company.

Daly‚ who was also the financial director of Cipla's Durban manufacturing facility‚ has been with the company for six years. Aucamp would remain with the company to help finalise the 2012 year-end audit and annual financial statements‚ and ensure a smooth hand over to Daly. It would make an announcement regarding the appointment of a new company secretary in due course‚ it said.

Earlier this month Cipla Medpro announced the appointment of two deputy chief executives‚ Mark Sardi and Skhumbuzo Ngozwana.


SOURCE

I-Net Bridge
For more than two decades, I-Net Bridge has been one of South Africa’s preferred electronic providers of innovative solutions, data of the highest calibre, reliable platforms and excellent supporting systems. Our products include workstations, web applications and data feeds packaged with in-depth news and powerful analytical tools empowering clients to make meaningful decisions.

We pride ourselves on our wide variety of in-house skills, encompassing multiple platforms and applications. These skills enable us to not only function as a first class facility, but also design, implement and support all our client needs at a level that confirms I-Net Bridge a leader in its field.
Go to: http://www.inet.co.za
    
 
LEGAL DISCLAIMER: This Message Board accepts no liability of legal consequences that arise from the Message Boards (e.g. defamation, slander, or other such crimes). All posted messages are the sole property of their respective authors. The maintainer does retain the right to remove any message posts for whatever reasons. People that post messages to this forum are not to libel/slander nor in any other way depict a company, entity, individual(s), or service in a false light; should they do so, the legal consequences are theirs alone. Bizcommunity.com will disclose authors' IP addresses to authorities if compelled to do so by a court of law.

Related news